Literature DB >> 10409435

Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.

J M Risk1, C Ruhrberg, H Hennies, H S Mills, T Di Colandrea, K E Evans, A Ellis, F M Watt, D T Bishop, N K Spurr, H P Stevens, I M Leigh, A Reis, D P Kelsell, J K Field.   

Abstract

Focal nonepidermolytic palmoplantar keratoderma (NEPPK), or tylosis, is an autosomal, dominantly inherited disorder of the skin that manifests as focal thickening of the palmar and plantar surfaces. In three families studied, the skin disorder cosegregates with esophageal cancer and oral lesions. New haplotype analysis, presented here, places the tylosis esophageal cancer (TOC) locus between D17S1839 and D17S785. Envoplakin (EVPL) is a protein component of desmosomes and the cornified envelope that is expressed in epidermal and esophageal keratinocytes and has been localized to the TOC region. Mutation analysis of EVPL in the three affected families failed to show tylosis-specific mutations, and haplotype analysis of three intragenic sequence polymorphisms of the EVPL gene placed it proximal to D17S1839. Confirmation of the exclusion of EVPL as the TOC gene by location was obtained by integration of the genetic and physical mapping data using radiation hybrid, YAC, BAC, and PAC clones. This new physical map will allow further identification of candidate genes underlying NEPPK associated with esophageal cancer, which may also be implicated in the development of sporadic squamous cell esophageal carcinoma and Barrett's adenocarcinoma. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409435     DOI: 10.1006/geno.1999.5857

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  Hereditary diffuse palmoplantar keratodermas in Slovenia: epidemiologic foci in remote rural areas.

Authors:  Jovan Miljković; Aleksej Kansky; Gaj Vidmar
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

2.  Abnormalities of chromosome 17 in oesophageal cancer.

Authors:  Revendran Moodley; Anunathan Reddi; Runjan Chetty; Richard Naidoo
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

3.  Modes of genetic adaptations underlying functional innovations in the rumen.

Authors:  Xiangyu Pan; Yudong Cai; Zongjun Li; Xianqing Chen; Rasmus Heller; Nini Wang; Yu Wang; Chen Zhao; Yong Wang; Han Xu; Songhai Li; Ming Li; Cunyuan Li; Shengwei Hu; Hui Li; Kun Wang; Lei Chen; Bin Wei; Zhuqing Zheng; Weiwei Fu; Yue Yang; Tingting Zhang; Zhuoting Hou; Yueyang Yan; Xiaoyang Lv; Wei Sun; Xinyu Li; Shisheng Huang; Lixiang Liu; Shengyong Mao; Wenqing Liu; Jinlian Hua; Zhipeng Li; Guojie Zhang; Yulin Chen; Xihong Wang; Qiang Qiu; Brian P Dalrymple; Wen Wang; Yu Jiang
Journal:  Sci China Life Sci       Date:  2020-11-05       Impact factor: 6.038

4.  Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene.

Authors:  Joanne E Langan; Charlotte G Cole; Elisabeth J Huckle; Shaun Byrne; Fiona E McRonald; Lynn Rowbottom; Anthony Ellis; Joan M Shaw; Irene M Leigh; David P Kelsell; Ian Dunham; John K Field; Janet M Risk
Journal:  Hum Genet       Date:  2004-03-09       Impact factor: 4.132

5.  RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Authors:  Diana C Blaydon; Sarah L Etheridge; Janet M Risk; Hans-Christian Hennies; Laura J Gay; Rebecca Carroll; Vincent Plagnol; Fiona E McRonald; Howard P Stevens; Nigel K Spurr; D Timothy Bishop; Anthony Ellis; Janusz Jankowski; John K Field; Irene M Leigh; Andrew P South; David P Kelsell
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

6.  Down-regulation in multiple human cancers of a novel gene, DMHC, from 17q25.1 that encodes an integral membrane protein.

Authors:  I Mikami; H Harada; H Nagai; M Tsuneizumi; Y Nobe; K Koizumi; S Sugano; S Tanaka; M Emi
Journal:  Jpn J Cancer Res       Date:  2001-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.